Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies.

Fakhouri F, Frémeaux-Bacchi V.

Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1682-1683. doi: 10.2215/CJN.12111019. Epub 2019 Nov 6. No abstract available.

PMID:
31811084
2.

Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome in solid organ transplant recipients.

Ville S, Ydee A, Garandeau C, Canet E, Tissot A, Cantarovich D, Frémeaux-Bacchi V, Mariani-Kurkdjian P, Provôt F, Fakhouri F.

Kidney Int. 2019 Dec;96(6):1423-1424. doi: 10.1016/j.kint.2019.08.024. No abstract available.

PMID:
31759490
3.

Influence of spray drying on bioactive compounds of blackberry pulp microencapsulated with arrowroot starch and gum arabic mixture.

Nogueira GF, Soares CT, Martin LGP, Fakhouri FM, de Oliveira RA.

J Microencapsul. 2019 Nov 26:1-12. doi: 10.1080/02652048.2019.1693646. [Epub ahead of print]

PMID:
31724471
4.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Dec;30(12):2449-2463. doi: 10.1681/ASN.2019040331. Epub 2019 Oct 1.

PMID:
31575699
5.

Active Edible Films Based on Arrowroot Starch with Microparticles of Blackberry Pulp Obtained by Freeze-Drying for Food Packaging.

Nogueira GF, Fakhouri FM, Velasco JI, de Oliveira RA.

Polymers (Basel). 2019 Aug 23;11(9). pii: E1382. doi: 10.3390/polym11091382.

6.

The authors reply.

Le Clech A, Frémeaux-Bacchi V, Fakhouri F.

Kidney Int. 2019 Aug;96(2):517-518. doi: 10.1016/j.kint.2019.04.010. No abstract available.

PMID:
31331469
7.

Magnetic resonance elastography of the lungs: A repeatability and reproducibility study.

Fakhouri F, Dong H, Kolipaka A.

NMR Biomed. 2019 Jul;32(7):e4102. doi: 10.1002/nbm.4102. Epub 2019 May 14.

PMID:
31087728
8.

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.

Le Clech A, Simon-Tillaux N, Provôt F, Delmas Y, Vieira-Martins P, Limou S, Halimi JM, Le Quintrec M, Lebourg L, Grangé S, Karras A, Ribes D, Jourde-Chiche N, Rondeau E, Frémeaux-Bacchi V, Fakhouri F.

Kidney Int. 2019 Jun;95(6):1443-1452. doi: 10.1016/j.kint.2019.01.023. Epub 2019 Mar 15.

PMID:
30982675
9.

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study.

Menne J, Delmas Y, Fakhouri F, Kincaid JF, Licht C, Minetti EE, Mix C, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.

Clin Kidney J. 2018 May 16;12(2):196-205. doi: 10.1093/ckj/sfy035. eCollection 2019 Apr.

10.

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Menne J, Delmas Y, Fakhouri F, Licht C, Lommelé Å, Minetti EE, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.

BMC Nephrol. 2019 Apr 10;20(1):125. doi: 10.1186/s12882-019-1314-1.

11.

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome.

El Karoui K, Boudhabhay I, Petitprez F, Vieira-Martins P, Fakhouri F, Zuber J, Aulagnon F, Matignon M, Rondeau E, Mesnard L, Halimi JM, Frémeaux-Bacchi V.

Haematologica. 2019 Dec;104(12):2501-2511. doi: 10.3324/haematol.2019.216903. Epub 2019 Mar 19.

12.

Etiology and Outcomes of Thrombotic Microangiopathies.

Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):557-566. doi: 10.2215/CJN.11470918. Epub 2019 Mar 12.

PMID:
30862697
13.

Bioactive films of arrowroot starch and blackberry pulp: Physical, mechanical and barrier properties and stability to pH and sterilization.

Nogueira GF, Soares CT, Cavasini R, Fakhouri FM, de Oliveira RA.

Food Chem. 2019 Mar 1;275:417-425. doi: 10.1016/j.foodchem.2018.09.054. Epub 2018 Sep 10.

PMID:
30724216
14.

C3 glomerulopathy - understanding a rare complement-driven renal disease.

Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM.

Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Review.

15.

Endothelium structure and function in kidney health and disease.

Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT.

Nat Rev Nephrol. 2019 Feb;15(2):87-108. doi: 10.1038/s41581-018-0098-z. Review.

PMID:
30607032
16.

Spinal-epidural Abscess Presenting as an Acute Abdomen in a Child: A Case Report and Review of the Literature.

Fakhouri F, Ghazal A, Alnaeb H, Hezan R, Araj J.

Asian J Neurosurg. 2018 Oct-Dec;13(4):1247-1249. doi: 10.4103/ajns.AJNS_177_17.

17.

Lymph node syndrome associated with cat scratch disease in children and adults.

Hozáková L, Rožnovský L, Fakhouri F, Doležílková J, Janout V.

Cas Lek Cesk. Summer 2018;157(3):146-151.

PMID:
30441948
18.

Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Néel A, Bucchia M, Néel M, Tilly G, Caristan A, Yap M, Rimbert M, Bruneau S, Cadoux M, Agard C, Hourmant M, Godmer P, Brouard S, Bressollette C, Hamidou M, Josien R, Fakhouri F, Degauque N.

Arthritis Rheumatol. 2019 Apr;71(4):641-650. doi: 10.1002/art.40766. Epub 2019 Mar 8.

PMID:
30375745
19.

In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'.

Le Quintrec M, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Dec;72(6):906-907. doi: 10.1053/j.ajkd.2018.08.005. Epub 2018 Sep 17. No abstract available.

PMID:
30236629
20.

Anticomplement Treatment in Atypical and Typical Hemolytic Uremic Syndrome.

Fakhouri F, Loirat C.

Semin Hematol. 2018 Jul;55(3):150-158. doi: 10.1053/j.seminhematol.2018.04.009. Epub 2018 Apr 20. Review.

PMID:
30032752
21.

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, Lommelé Å, Kupelian V, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Licht C, Vande Walle J, Frémeaux-Bacchi V; Global aHUS Registry.

Kidney Int. 2018 Aug;94(2):408-418. doi: 10.1016/j.kint.2018.02.029. Epub 2018 Jun 19.

PMID:
29907460
22.

Extraction and characterization of arrowroot (Maranta arundinaceae L.) starch and its application in edible films.

Nogueira GF, Fakhouri FM, de Oliveira RA.

Carbohydr Polym. 2018 Apr 15;186:64-72. doi: 10.1016/j.carbpol.2018.01.024. Epub 2018 Jan 9.

23.

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

Le Quintrec M, Lapeyraque AL, Lionet A, Sellier-Leclerc AL, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.

PMID:
29429752
24.

Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation.

Néel A, Espitia-Thibault A, Arrigoni PP, Volteau C, Rimbert M, Masseau A, Agard C, Fakhouri F, Liberge R, Hamidou M.

Semin Arthritis Rheum. 2018 Aug;48(1):70-76. doi: 10.1016/j.semarthrit.2017.12.002. Epub 2017 Dec 7.

PMID:
29336783
25.

Cardiovascular magnetic resonance elastography: A review.

Khan S, Fakhouri F, Majeed W, Kolipaka A.

NMR Biomed. 2018 Oct;31(10):e3853. doi: 10.1002/nbm.3853. Epub 2017 Nov 29. Review.

26.

Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders.

Vanhove B, Poirier N, Fakhouri F, Laurent L, 't Hart B, Papotto PH, Rizzo LV, Zaitsu M, Issa F, Wood K, Soulillou JP, Blancho G.

Antibodies (Basel). 2017 Nov 21;6(4). pii: E19. doi: 10.3390/antib6040019. Review.

27.

Factors Correlated with Unfavorable Outcome after Carpal Tunnel Release Surgery.

Fakhouri F, Alsukhni RA, Altunbi B, Hawoot Z, Dabbagh R.

Asian J Neurosurg. 2017 Oct-Dec;12(4):670-673. doi: 10.4103/ajns.AJNS_3_15.

28.

Pregnancy-related acute kidney injury in high income countries: still a critical issue.

Fakhouri F, Deltombe C.

J Nephrol. 2017 Dec;30(6):767-771. doi: 10.1007/s40620-017-0440-8. Epub 2017 Sep 27. Review.

PMID:
28956309
29.

[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis].

Rafat C, Coppo P, Fakhouri F, Frémeaux-Bacchi V, Loirat C, Zuber J, Rondeau E.

Rev Med Interne. 2017 Dec;38(12):833-839. doi: 10.1016/j.revmed.2017.07.005. Epub 2017 Sep 22. Review. French.

PMID:
28947259
30.

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.

Marinozzi MC, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V.

Kidney Int. 2017 Nov;92(5):1232-1241. doi: 10.1016/j.kint.2017.04.017. Epub 2017 Jul 14.

PMID:
28712854
31.

[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].

Rafat C, Coppo P, Fakhouri F, Frémeaux-Bacchi V, Loirat C, Zuber J, Rondeau E.

Rev Med Interne. 2017 Dec;38(12):817-824. doi: 10.1016/j.revmed.2017.06.004. Epub 2017 Jul 12. Review. French.

PMID:
28711159
32.

Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.

Laurent L, Le Fur A, Bloas RL, Néel M, Mary C, Moreau A, Poirier N, Vanhove B, Fakhouri F.

Eur J Immunol. 2017 Aug;47(8):1368-1376. doi: 10.1002/eji.201746923. Epub 2017 Jul 10.

33.

Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EKS, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1237-1247. doi: 10.2215/CJN.00280117. Epub 2017 Jun 8.

34.

Neurosurgery under siege - Stories from Aleppo and the Syrian war: A narrative article.

Fakhouri F.

Asian J Neurosurg. 2017 Apr-Jun;12(2):342-343. doi: 10.4103/ajns.AJNS_59_17. No abstract available.

35.

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.

Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.

PMID:
28434948
36.

Haemolytic uraemic syndrome.

Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C.

Lancet. 2017 Aug 12;390(10095):681-696. doi: 10.1016/S0140-6736(17)30062-4. Epub 2017 Feb 25. Review. Erratum in: Lancet. 2017 Aug 12;390(10095):648.

PMID:
28242109
37.

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ; Conference Participants.

Kidney Int. 2017 Mar;91(3):539-551. doi: 10.1016/j.kint.2016.10.005. Epub 2016 Dec 16.

38.

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.

Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):50-59. doi: 10.2215/CJN.06440616. Epub 2016 Oct 31.

39.

Pregnancy-related thrombotic microangiopathies: Clues from complement biology.

Fakhouri F.

Transfus Apher Sci. 2016 Apr;54(2):199-202. doi: 10.1016/j.transci.2016.04.009. Epub 2016 Apr 25. Review.

PMID:
27158062
40.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.

Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.

41.

[Clinical approach to primary membranoproliferative glomerulonephritis].

Fakhouri F.

Nephrol Ther. 2016 Apr;12 Suppl 1:S65-9. doi: 10.1016/j.nephro.2016.01.008. Epub 2016 Mar 10. French.

PMID:
26972096
42.

Giant hydatid cyst in the posterior fossa of a child.

Fakhouri F, Ghajar A, Mahli N, Shoumal N.

Asian J Neurosurg. 2015 Oct-Dec;10(4):322-4. doi: 10.4103/1793-5482.162719.

43.

[Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases].

Lioger B, Yahiaoui Y, Kahn JE, Fakhouri F, Belenfant X, Papo T, Magnant J, Maillot F, Vordos D, Godeau B, Michel M.

Rev Med Interne. 2016 Jun;37(6):387-93. doi: 10.1016/j.revmed.2015.08.013. Epub 2015 Sep 26. French.

PMID:
26415922
44.

Translational implications of endothelial cell dysfunction in association with chronic allograft rejection.

Bruneau S, Wedel J, Fakhouri F, Nakayama H, Boneschansker L, Irimia D, Daly KP, Briscoe DM.

Pediatr Nephrol. 2016 Jan;31(1):41-51. doi: 10.1007/s00467-015-3094-6. Epub 2015 Apr 24. Review.

45.

An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V; HUS International.

Pediatr Nephrol. 2016 Jan;31(1):15-39. doi: 10.1007/s00467-015-3076-8. Epub 2015 Apr 11. Review.

PMID:
25859752
46.

Eculizumab for treatment of rapidly progressive C3 glomerulopathy.

Le Quintrec M, Lionet A, Kandel C, Bourdon F, Gnemmi V, Colombat M, Goujon JM, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2015 Mar;65(3):484-9. doi: 10.1053/j.ajkd.2014.09.025. Epub 2014 Dec 17.

PMID:
25530108
47.

Loss of DGKε induces endothelial cell activation and death independently of complement activation.

Bruneau S, Néel M, Roumenina LT, Frimat M, Laurent L, Frémeaux-Bacchi V, Fakhouri F.

Blood. 2015 Feb 5;125(6):1038-46. doi: 10.1182/blood-2014-06-579953. Epub 2014 Dec 10.

PMID:
25498910
48.

Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation.

Le Berre L, Dufay A, Cantarovich D, Meurette A, Audrain M, Giral M, Blancho G, Fakhouri F, Hourmant M, Dantal J.

Clin Nephrol. 2015 Jun;83(6):357-62. doi: 10.5414/CN108303.

PMID:
25345380
49.

Primary Ewing's sarcoma of the anterior fontanelle in a neonate.

Fakhouri FZ, Frasheh CN.

Saudi Med J. 2014 Jul;35(7):739-42.

PMID:
25028233
50.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.

Nephrol Dial Transplant. 2014 Nov;29(11):2084-91. doi: 10.1093/ndt/gfu209. Epub 2014 Jun 11.

PMID:
24920841

Supplemental Content

Loading ...
Support Center